Protease inhibitors bind to the active
site of the HIV proteases and prevent the enzymes from attaching to its substrate
and cleaving the HIV gag, gag-pol, and env polyproteins into functional proteins. As a result, HIV can
not mature and non-infectious viruses are produced.